Dermatological Medications and Local Therapeutics During Pregnancy

    September 2014 in “ Elsevier eBooks ”
    Christof Schaefer, Gudula Kirtschig
    Studysummary This review discusses the safety of dermatological medications used during pregnancy, highlighting that retinoids have strong teratogenic risks and should be used with caution; it reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sciencedirect.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Adverse Effects of Isotretinoin: A Retrospective Review of 1743 Patients Australasian Journal of Dermatology · 2010
    2. Aphalangia Possibly Linked to Unintended Use of Finasteride During Early Pregnancy Annals of Saudi Medicine · 2009
    3. Topically Applied Minoxidil May Cause Fetal Malformation: A Case Report Teratology · 2003
    4. Safety of Topical Minoxidil Solution: A One-Year, Prospective, Observational Study Journal of Cutaneous Medicine and Surgery · 2003

    Related research 1

    1. Isotretinoin-Unresponsive Acne as a Sign of a Congenital Disorder: A Case of 21-Hydroxylase Deficiency Dermatology Reports · 2023